Faculty
Oncology Division
Keith E. Stockerl-Goldstein, MD
Professor
Department of Medicine
Oncology Division
Bone Marrow Transplantation & Leukemia
Clinical Interests
- Multiple myeloma / amyloidosis
- Leukemia
- Hodgkin's disease
- Non-Hodgkin's lymphoma
- Myelodysplastic syndrome
- Stem cell transplantation
Contact
- 314-454-8304 (office)
- 314-454-7551 (fax)
- ksgoldstein@wustl.edu
- Division of Oncology
Mail Stop 8007-0029-11
Washington University
660 South Euclid Avenue
St. Louis, MO 63110 - 11th Floor Mid Campus Center (office)
Biosketch
| Education | |
|---|---|
| 1982-1986 | BA in Biology, Washington University, St. Louis, MO |
| 1986-1988; 1989-1991 |
MD, UCLA School of Medicine, Los Angeles, CA |
| Professional Experience | |
| 1988-1989 | Post-Sophomore Fellowship in Pathology, St. Louis University School of Medicine, St. Louis, MO |
| 1991-1993 | Internal Medicine Internship and Residency, Stanford University Hospital, Stanford, CA |
| 1993-1996 | Fellowship in Medical Oncology, Stanford University School of Medicine, Stanford, CA |
| 1995 | Fellowship in Bone Marrow Transplantation, Stanford University School of Medicine, Stanford, CA |
| Academic Positions & Employment | |
| 1996-1998 | Staff Physician and Clinical Instructor of Medicine, Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA |
| 1996-2002 | Clinical Director, Adult Bone Marrow Transplantation Unit, Stanford University School of Medicine, Stanford, CA |
| 1998-2003 | Assistant Professor of Medicine, Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA |
| 2003-2007 | Associate Professor of Medicine, Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA |
| 2007-2019 | Associate Professor of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO |
| 2019-present | Professor of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO |
| University & Hospital Appointments &Committees | |
| 1996-2001 | TPN Committee, Stanford University School of Medicine |
| 1996-2007 | Stanford Bone Marrow Transplant Review Committee |
| 1999-2007 | Stanford Hospital Ethics Committee |
| 2004-2007 | Institutional Review Board on Human Subjects in Medical Research (2 Panels), Stanford University |
| 2007-2010 | Protocol Review and Monitoring Committee, Siteman Cancer Center |
| 2007-present | Formulary Subcommittee, Pharmacy and Therapeutics Committee |
| 2009-present | Medical Director CIBMTR for Washington University BMT Program |
| 2016-present | Oncology/BMT EPIC Physician Champion |
| 2017-present | Clinical Competency Committee, Hematology Oncology Fellowship Program Chair, 2019-present |
| 2019-present | Associate Program Director, Hematology Oncology Fellowship Program |
| 2021-present | Co-Chair, Washington University Amyloid Center of Excellence |
| Board Certification | |
| 1996-2006 | Internal Medicine Board Certification, American Board of Internal Medicine |
| 1997 | Medical Oncology Board Certification, American Board of Internal Medicine |
| 2008 | Medical Oncology Board Re-Certification, American Board of Internal Medicine |
| 2018 | Medical Oncology Board Re-Certification, American Board of Internal Medicine |
| Honors & Awards | |
| 1986 | Washington University, BA, Cum Laude |
| 1986 | Phi Beta Kappa |
| 1986-1991 | Regent's Scholar, UCLA School of Medicine |
| 1991 | Alpha Omega Alpha, Delta Chapter |
| 1999 | Senior Research Award, Myeloma Research Foundation |
| 1999-2002 | Faculty Scholar Award, Center for Clinical Immunology at Stanford |
| 2001 | Department of Medicine Divisional Teaching Award |
| 2008-2021 | Washington University Physicians Top Provider |
| 2019-2022 | Best Doctors in America |
| National Scientific Panels | |
| 1997-present | National Comprehensive Cancer Network, Myeloma Panel |
| 2011-present | ASBMT Informatics Committee |
| 2016-present | CIBMTR EMR User Group |
| 2016-present | National Comprehensive Cancer Network, EHR Oncology Advisory Group |
| 2020-present | Co-Chair, International Cardio-Oncology Society Amyloidosis Working Group |
| Professional Societies | |
| American Society for Transplantation and Cellular Therapy | |
| American Society of Clinical Oncology | |
| American Society of Hematology | |
| International Cardio-Oncology Society | |
| International Society of Amyloidosis | |
